technetium tc 99m sestamibi has been researched along with Angioma, Sclerosing in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basdemir, G; Burak, Z; Dirlik, A; Erinç, R; Ersoy, O; Moretti, JL; Ozcan, Z; Sabah, D | 1 |
Aktolun, C; Berk, F; Demir, H; Ercin, C | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Angioma, Sclerosing
Article | Year |
---|---|
The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Child; Drug Resistance, Multiple; Female; Histiocytoma, Benign Fibrous; Humans; Immunohistochemistry; Male; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Osteosarcoma; Phenotype; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Technetium Tc 99m Sestamibi | 2001 |
Tc-99m MIBI imaging in malignant fibrous histiocytoma.
Topics: Aged; Female; Forearm; Histiocytoma, Benign Fibrous; Humans; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Technetium Tc 99m Sestamibi | 2001 |